NCT07215559: A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
- State
- Under way
- Phase
- Phase 2
- People
- 200 planned
- Started
- 16 Oct 2025
- Primary completion
- Mar 2027
- Arms
- Macupatide + Eloralintide
- Results
- None posted
- 10 Oct 2025: Trial registered
- 16 Oct 2025: Trial started